IRON - NASDAQ

Disc Medicine, Inc.

IRON·NASDAQ

$70.35

-2.3%

HealthcareBiotechnology

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$2.69B

EPS-6.0100

P/E Ratio-11.71

Earnings Date08/06/2026

iron

Stock Based Compensation

Last Annual Value

34.34M

3-Year CAGR

154%

5-Year CAGR

104%

10-Year CAGR

43%

Adjust for Inflation

Disc Medicine, Inc. Competitors Analysis of Stock Based Compensation

IRON · NASDAQ

Company	Stock Based Compensation	CAGR 3Y	CAGR 5Y	CAGR 10Y
Disc Medicine, Inc. NASDAQ:IRON	34.34M	83.8%	132.4%	N/A
Tarsus Pharmaceuticals, Inc. NASDAQ:TARS	41.72M	28.1%	37.6%	N/A
Celcuity Inc. NASDAQ:CELC	21.38M	63.4%	52.3%	60.6%
CG Oncology, Inc. Common stock NASDAQ:CGON	26.68M	159.4%	88.8%	N/A
Apogee Therapeutics, Inc. NASDAQ:APGE	46.28M	96.5%	N/A	N/A
Adaptive Biotechnologies Corporation NASDAQ:ADPT	51.48M	N/A	N/A	N/A
Legend Biotech Corporation NASDAQ:LEGN	0.00	N/A	N/A	N/A
Scholar Rock Holding Corporation NASDAQ:SRRK	75.60M	40.7%	26.7%	63.4%

Disc Medicine, Inc. Fair Value Envelope

IRON · NASDAQ

Our analysis suggests that IRON has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $70.35, this represents a potential HIDDEN relative to our calculated worth for Disc Medicine, Inc..

HIDDEN

Intrinsic Value

Current Price: $70.35

Related Guides

Blog Categories

Continue your IRON research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.